Compare Stocks

→ The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACST Acasti Pharma	$2.94 +2.1%	$3.33	$1.72 ▼ $3.84	$27.07M	1.49	27,929 shs	8,422 shs
IMV IMV		$0.66	$0.48 ▼ $12.70	$9.63M	0.95	233,607 shs	44,800 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACST Acasti Pharma	+2.08%	-7.26%	-13.78%	+23.01%	+3.14%
IMV IMV	0.00%	0.00%	0.00%	0.00%	+1.54%

The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACST Acasti Pharma	2.5302 of 5 stars	3.5	5.0	0.0	0.0	0.6	0.8	1.3
IMV IMV	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACST Acasti Pharma	3.00	Buy	$6.00	104.08% Upside
IMV IMV	2.00	Hold	N/A	N/A

Current Analyst Ratings

Latest IMV, ACST, and BOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
2/7/2024	ACST Acasti Pharma	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$6.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACST Acasti Pharma	N/A	N/A	N/A	N/A	$9.14 per share	N/A
IMV IMV	$330K	0.00	N/A	N/A	($0.69) per share	0.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACST Acasti Pharma	-$42.43M	-$5.08	N/A	N/A	N/A	N/A	-13.18%	-11.32%	6/28/2024 (Estimated)
IMV IMV	-$37.99M	-$4.59	N/A	N/A	N/A	-11,547.42%	-12,695.41%	-104.84%	N/A

Latest IMV, ACST, and BOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/12/2024	12/31/2023	ACST Acasti Pharma	-$0.23	-$0.21	+$0.02	-$0.21	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACST Acasti Pharma	N/A	N/A	N/A	N/A	N/A
IMV IMV	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACST Acasti Pharma	N/A	15.19	15.19
IMV IMV	N/A	2.93	2.93

Ownership

Institutional Ownership

Company	Institutional Ownership
ACST Acasti Pharma	6.08%
IMV IMV	15.37%

Insider Ownership

Company	Insider Ownership
ACST Acasti Pharma	13.51%
IMV IMV	0.33%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ACST Acasti Pharma	32	9.40 million	8.13 million	Not Optionable
IMV IMV	97	11.71 million	11.67 million	Optionable

IMV, ACST, and BOT Headlines

Source	Headline
	Philippines growth slows sharply in March just-auto.com - April 23 at 9:42 AM
	Why it’s likely Toyota will revive the ‘Stallion’ badge in SA cars.co.za - April 18 at 1:41 AM
	GWC introduces vision picking technology in Qatar zawya.com - April 16 at 8:13 AM
	Holliday's first hit helps the Orioles rally to a 6-4 win over the Brewers and avoid a sweep wsbtv.com - April 14 at 6:46 PM
	Golden Bachelor news: Gerry and Theresa break up, but still love each other msn.com - April 13 at 9:37 AM
	The future Toyota EVs that could trump Tesla just-auto.com - April 9 at 7:56 PM
	The Pros And Cons Of Owning Toyota's $13,000 Pickup Truck msn.com - April 7 at 10:44 AM
	Bangkok 2024: Toyota Hilux Champ – workhorse truck; SWB and LWB; petrol/diesel; 5MT/6AT; from RM59k paultan.org - April 5 at 7:24 AM
	Toyota's Wacky Front and Rear Sliding Door Crossover Van Comes to Life Digitally autoevolution.com - April 4 at 7:13 AM
	Why are there so many cars in Omaha without license plates? msn.com - April 3 at 7:17 PM
	Toyota's stout, crazy-modular $12K tiny truck makes enticing mini-RV newatlas.com - April 3 at 7:17 PM
	Virginia Tech hires Marquette's Megan Duffy as new coach msn.com - April 3 at 2:17 PM
	CalciMedica, Inc.: CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates finanznachrichten.de - March 28 at 11:06 AM
	Philippines sales up in February 2024 msn.com - March 27 at 6:30 PM
	Philippines sales rise in February just-auto.com - March 27 at 8:30 AM
	An Electric Toyota Hilux Is Reportedly Coming by 2025 msn.com - March 26 at 2:02 PM
	The New FJ Cruiser Could Use Toyota's $13,000 Truck Platform msn.com - March 26 at 9:01 AM
	Asian hornet may have become established in UK, sighting suggests theguardian.com - March 25 at 5:59 PM
	New ultrasound software designed to help vets give better bovine breeding advice vetsurgeon.org - March 25 at 5:59 PM
	Toyota FJ Cruiser reboot rumored to sit on Hilux Champ chassis autoblog.com - March 25 at 12:57 PM
	BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT finanznachrichten.de - March 22 at 7:21 PM
	2024 Toyota Zenix Hybrid Review autodeal.com.ph - March 21 at 8:53 PM
	BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update finance.yahoo.com - March 21 at 8:53 PM
	Hyundai ST-1 is a commercial EV with Staria face autoindustriya.com - March 18 at 2:10 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Acasti Pharma

NASDAQ:ACST

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

IMV

NASDAQ:IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial